Internet therapy for prolonged grief disorder

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of internet-delivered Cognitive Behavioral Therapy (iCBT) in reducing symptoms of prolonged grief disorder in adults who have lost a loved one. Participants will be randomly assigned to either the iCBT group, an active control group, or a waitlist control group. The study aims to assess the short and long-term effects of iCBT on symptoms of prolonged grief, posttraumatic stress, and depression, while also exploring the mechanisms that contribute to its effectiveness. Follow-up assessments will be conducted at 6 and 12 months post-treatment to gauge the lasting impact of the intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Currently residing in Sweden
* Lost a relative or close friend to any cause of death at least six months ago
* Suffers from prolonged grief disorder

Exclusion Criteria:

* Ongoing severe psychiatric problems that may prevent treatment implementation or require more urgent care (e.g., participants with untreated psychotic disorder, untreated bipolar disorder, ongoing substance abuse, elevated suicide risk)
* Change in dosage of any medication for mental health issues (e.g., antidepressant medication) in the past four weeks or in the next two months

Where it's running

• Region Uppsala, KBT via nätet, Nära vård digitalt
  Uppsala, Sweden Recruiting
• Uppsala university, Dep of Womens and Childrens Health
  Uppsala, Sweden Recruiting

Study contacts

• Study coordinator: Josefin Sveen, Professor
• Email: josefin.sveen@uu.se
• Phone: +46 738 66 70 87

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Noninvasive brain stimulation to help prolonged grief

  This study tests whether repetitive transcranial magnetic stimulation (rTMS) can help adults with prolonged grief disorder who are coping poorly.

  Recruiting Bruyère Health Research Institute. · Ottawa, Ontario · NCT06953596

• Psilocybin to help people with prolonged grief disorder

  This study will test whether a single 25 mg dose of psilocybin can reduce grief and trauma symptoms in adults with prolonged grief disorder.

  Recruiting Early Phase 1 University of Virginia · Charlottesville, Virginia · NCT06724289

• 8-week mindfulness program for adults with prolonged grief disorder

  This pilot tries an 8-week mindfulness training to see if it reduces grief symptoms and lowers stress-related brain and body responses in adults aged 18–60 with prolonged grief disorder.

  Recruiting University Hospital, Caen · Caen, Calvados · NCT06017765

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.